OpenURL Connection Search

Select item for more details and to access through your institution.

Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B‐cell lymphoma, leg type.
Published in:
British Journal of Haematology, 2022, v. 196, n. 4, p. e30, doi. 10.1111/bjh.17886
By:
- Moore, Donald C.;
- Soni, Amy C.;
- Hu, Bei;
- Smith, Elton T.;
- Levine, Jonathan;
- Moyo, Tamara K.;
- Jacobs, Ryan;
- Ghosh, Nilanjan;
- Park, Steven I.
Publication type:
Article
Re-examining the role of hematopoietic stem cell transplantation in relapsed large B-cell lymphoma in the era of chimeric antigen receptor (CAR) T-cell therapy.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1397186
By:
- Moyo, Tamara K.;
- Vaidya, Rakhee
Publication type:
Article
Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Published in:
American Journal of Hematology, 2016, v. 91, p. 371, doi. 10.1002/ajh.24291
By:
- Bouchnita, Anass;
- Eymard, Nathalie;
- Moyo, Tamara K.;
- Koury, Mark J.;
- Volpert, Vitaly
Publication type:
Article
Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Published in:
American Journal of Hematology, 2016, v. 91, n. 4, p. 371, doi. 10.1002/ajh.24291
By:
- Bouchnita, Anass;
- Eymard, Nathalie;
- Moyo, Tamara K.;
- Koury, Mark J.;
- Volpert, Vitaly
Publication type:
Article
The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
Published in:
BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10073-w
By:
- Moyo, Tamara K.;
- Mendler, Jason H.;
- Itzykson, Raphael;
- Kishtagari, Ashwin;
- Solary, Eric;
- Seegmiller, Adam C.;
- Gerds, Aaron T.;
- Ayers, Gregory D.;
- Dezern, Amy E.;
- Nazha, Aziz;
- Valent, Peter;
- van de Loosdrecht, Arjan A.;
- Onida, Francesco;
- Pleyer, Lisa;
- Cirici, Blanca Xicoy;
- Tibes, Raoul;
- Geissler, Klaus;
- Komrokji, Rami S.;
- Zhang, Jing;
- Germing, Ulrich
Publication type:
Article
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
Published in:
2022
By:
- Moyo, Tamara K.;
- Mendler, Jason H.;
- Itzykson, Raphael;
- Kishtagari, Ashwin;
- Solary, Eric;
- Seegmiller, Adam C.;
- Gerds, Aaron T.;
- Ayers, Gregory D.;
- Dezern, Amy E.;
- Nazha, Aziz;
- Valent, Peter;
- van de Loosdrecht, Arjan A.;
- Onida, Francesco;
- Pleyer, Lisa;
- Cirici, Blanca Xicoy;
- Tibes, Raoul;
- Geissler, Klaus;
- Komrokji, Rami S.;
- Zhang, Jing;
- Germing, Ulrich
Publication type:
journal article
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01316-1
By:
- Epperla, Narendranath;
- Zhao, Qiuhong;
- Chowdhury, Sayan Mullick;
- Shea, Lauren;
- Moyo, Tamara K.;
- Reddy, Nishitha;
- Sheets, Julia;
- Weiner, David M.;
- Geethakumari, Praveen Ramakrishnan;
- Kandarpa, Malathi;
- Bruno, Ximena Jordan;
- Thomas, Colin;
- Churnetski, Michael C.;
- Hsu, Andrew;
- Zurbriggen, Luke;
- Tan, Cherie;
- Lindsey, Kathryn;
- Maakaron, Joseph;
- Caimi, Paolo F.;
- Torka, Pallawi
Publication type:
Article
Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B‐cell lymphoma.
Published in:
Cancer (0008543X), 2021, v. 127, n. 21, p. 3991, doi. 10.1002/cncr.33779
By:
- Hu, Bei;
- Boselli, Danielle;
- Pye, Lisa M.;
- Chen, Tommy;
- Bose, Rupali;
- Symanowski, James T.;
- Blackley, Kris;
- Moyo, Tamara K.;
- Jacobs, Ryan;
- Park, Steven I.;
- Soni, Amy;
- Avalos, Belinda R.;
- Copelan, Edward A.;
- Raghavan, Derek;
- Ghosh, Nilanjan
Publication type:
Article
A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma.
Published in:
OncoTargets & Therapy, 2021, v. 14, p. 2185, doi. 10.2147/OTT.S242018
By:
- Atrash, Shebli;
- Moyo, Tamara K
Publication type:
Article

Found: 9